Oxytocin may treat abdominal pain

January 31, 2014
Oxytocin may treat abdominal pain
Professor Alewood from UQ's IMB has developed a molecule that showed significant potential in alleviating abdominal pain.

(Medical Xpress)—Australian researchers have found a key to treating chronic abdominal pain may lie in a hormone that induces labour and encourages social bonding.

The researchers, led by The University of Queensland's Professor Paul Alewood from and the University of Adelaide's Dr Stuart Brierley, have developed a version of the to treat associated with conditions such as .

Oxytocin is known as 'the love drug' for its ability to enhance social interactions including maternal behaviour, partnership and bonding.

Professor Alewood, from UQ's Institute for Molecular Bioscience, said the molecule they had developed – a version of oxytocin with improved stability – showed significant potential in alleviating abdominal pain.

"It can potentially survive in the digestive tract until it reaches the gut," he said.

"This molecule acts on oxytocin nerve receptors in the bowel, which display increased sensitivity in conditions such as irritable bowel syndrome."

Professor Alewood said it had no effect on healthy gut tissue, which was an important advantage in drug development where minimising side effects is crucial.

Chronic abdominal pain is a major health problem, with irritable bowel syndrome alone affecting around 11 per cent of the Western population.

Despite the high number of sufferers, there are currently no drugs that directly treat abdominal pain.

The research was published overnight in the scientific journal Nature Communications.

Explore further: Peppermint earns respect in mainstream medicine

Related Stories

Biomarkers can reveal irritable bowel syndrome

May 7, 2012

Irritable bowel syndrome (IBS) is hard to diagnose as well as treat, but researchers at the Sahlgrenska Academy, at the University of Gothenburg, Sweden, have discovered a way of confirming the disorder using stool samples.

New drug approved for irritable bowel, chronic constipation

August 30, 2012

(HealthDay)—Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don't respond to traditional treatment, and irritable bowel syndrome accompanied by ...

New drug to help common bowel disease

October 29, 2013

(Medical Xpress)—An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical ...

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...

Computer model reveals deadly route of Ebola outbreak

November 10, 2015

Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.